SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study)
Clinical trial NCT01171820 · COMPLETED
Trial details
- NCT number
- NCT01171820
- Sponsor
- Abbott Medical Devices
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-11-01
- Primary completion
- 2009-07-01
- Enrollment
- 324
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.